Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial

Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients

(2016) Nuria Farré et al.   EUROPEAN JOURNAL OF HEART FAILURE

Calidad de vida relacionada con la salud de los pacientes con insuficiencia cardiaca crónica sistólica en España: resultados del estudio VIDA-IC

(2016) Josep Comín-Colet et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary disease management programmes for heart failure: Results of a randomized controlled trial

(2015) Josep Comín-Colet et al.   JOURNAL OF TELEMEDICINE AND TELECARE

Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial

(2014) Johann Altenberger et al.   EUROPEAN JOURNAL OF HEART FAILURE

Decongestion in acute heart failure

(2014) Robert J. Mentz et al.   EUROPEAN JOURNAL OF HEART FAILURE

Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus

(2014) M.S. Nieminen et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

(2013) Milton Packer et al.   JACC-Heart Failure

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

(2012) Scott D Solomon et al.   LANCET

Levosimendan: Molecular mechanisms and clinical implications

(2011) Zoltán Papp et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Oral levosimendan in patients with severe chronic heart failure-The PERSIST study

(2008) Markku S. Nieminen et al.   EUROPEAN JOURNAL OF HEART FAILURE

Repetitive Dosing of Intravenous Levosimendan Improves Pulmonary Hemodynamics in Patients With Pulmonary Hypertension: Results of a Pilot Study

(2008) Franz X. Kleber et al.   JOURNAL OF CLINICAL PHARMACOLOGY